Company profile: Enpicom
1.1 - Company Overview
Company description
- Provider of innovative bioinformatics software and customized solutions supporting biopharma and academic scientists in accelerating immunotherapy and vaccine discovery and development. Offers the cloud-based IGX Platform for immune repertoire sequencing analysis, plus Antibody Discovery, IGX-Track, IGX-Profile, IGX-Inspect, and IGX-Explore for annotation, QC, clustering, and interactive visualizations.
Products and services
- Antibody Discovery Module: A custom-engineered module that integrates sequence and assay data to enable clustering, phylogeny, and structural liability analyses in a secure environment
- IGX Platform: A cloud-native, cloud-based system that manages and analyzes immune repertoire sequencing data, supports varied data types, and delivers intuitive user interface and visualizations
- IGX-Profile: A scalable platform that annotates B and T cells from multiple species, supports various sequencing technologies, and ensures high-quality data through error correction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enpicom
GoBalto
HQ: United States
Website
- Description: Provider of cloud-based solutions for drug trial sponsors and clinical research organizations to simplify and accelerate clinical studies on the web. Offerings include tools for selecting, activating and analyzing clinical trial sites; a unified platform integrating people, processes and data; and safety case and signal management solutions supporting pharmacovigilance and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GoBalto company profile →
Octant
HQ: United States
Website
- Description: Provider of a cellular intelligence platform for studying protein misfolding in human cells and enabling high-throughput screening; multiplexed readouts to measure protein folding and trafficking across hundreds of mutations and conditions; and development of novel therapeutics guided by massive datasets in engineered human cells to improve health and treat disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Octant company profile →
Overwatch Research
HQ: United Kingdom
Website
- Description: Provider of all-in-one experimental tracking software for in vivo research, including Benchling In Vivo for study design and review, in-life data capture linked to treatments and groups, multi-parameter randomization, flexible task management and scheduling, and real-time data visualization from a centralized database to save time, reduce error, and increase collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Overwatch Research company profile →
FlowJo
HQ: United States
Website
- Description: Provider of life sciences software for flow cytometry and single-cell analysis, offering FlowJo for viewing and analyzing flow cytometric data (sample management, gating, statistics, graphical layouts), BD Research Cloud for secure cloud storage, sharing and collaboration with integration to analysis software, and SeqGeq for single-cell RNA sequencing (scRNA-seq) data analysis and visualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlowJo company profile →
Curio Bioscience
HQ: United States
Website
- Description: Provider of spatial transcriptomics tools for cancer biology, developmental biology, immunology, and neuroscience: Curio Seeker kits for whole transcriptome mapping of fresh-frozen tissues, compatible with eukaryotes and fitting sequencing workflows without specialized equipment; Curio Trekker for single-cell spatial mapping without deconvolution or segmentation; and the Seeker bioinformatics pipeline to process FASTQ into spatial maps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curio Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enpicom
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enpicom
2.2 - Growth funds investing in similar companies to Enpicom
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enpicom
4.2 - Public trading comparable groups for Enpicom
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →